Blogs

Categories

Select a Sub-Category

Films and Coatings
Pharmaceutical Packaging Components
Prefillable Systems
Self Injection Devices
Vial Containment Solutions
Washing and Sterilization
Reconstitution and Transfer Devices

Select a Sub-Category

Analytical Lab Services
Contract Manufacturing
Fill-Finish
Regulatory Support

Select a Sub-Category

Cell and Gene Therapy Packaging
Drug Development Process
Regulatory Challenges
Transitioning to Combination Products

Select a Sub-Category

Corporate Development
ESG/Sustainability
One West Team (Employee Culture)
Our Culture of Giving (Philanthropy)
Research and Development

Previous Blogs

Stoppers and Plungers
Envision Vision Inspection Packaging Delivery Systems Quality
Mitigating Risk in Pharmaceutical Manufacturing with Visually-Inspected Components

By Olga Laskina, Ph.D.

七月 10, 2020

The overall quality of a final drug product depends on the components of its packaging and delivery systems.  The use of visually inspected components reduces the risk of defective components and helps ensure patient safety.

Read More
Stoppers and plungers
Packaging Containment Systems Delivery Systems Components
West Educational Series: The Impact of Yesterday’s Packaging on Today’s Drugs and Tomorrow’s Applications

By Bjoern Henze, Ph.D.

一月 10, 2020

Read More
SmartDose Delivery Platform
Biologics Delivery Systems
Evolution in Biologic Drug Products – Need for Administration of High Viscosities

By Frederike Ferber

三月 12, 2018

Biologic drug products are not new – their development began decades ago; the first monoclonal antibody was commercialized in 1986. [1] With the increasing availability of genetic information, and better understanding of subcellular cascades and disease processes, the number of biologic drug products available has increased substantially in response to an exponential growth in targets. [2]

Read More
The SmartDose Platform in use
Injectables Delivery Systems
Drug Pipeline Driving Market Needs for Delivery System Technologies

By Fran DeGrazio

四月 05, 2017

Industry meetings continue to reinforce the changing landscape of the drug pipeline and the influence of biologic drug products in driving this change.  At the recent DCAT Week, hosted by the Drug, Chemical and Associated Technologies Association, Josef Bossart, of PharmaCircle, provided an excellent overview of historic trends and current forecasts.

Read More